CNS stimulants and the look-alike drugs
- PMID: 6151645
CNS stimulants and the look-alike drugs
Abstract
Abuse of amphetamine and especially the stimulant look-alikes represent a serious problem in the United States. The danger of amphetamine lies in its ability to produce tolerance, psychological addiction, psychosis, hypertensive crisis, and major depression following withdrawal after long-term use. The danger of the look-alikes is of a psychosocial nature and has less to do with the physical properties of the drugs. Easy availability and a casual attitude toward these drugs may introduce children and young adults to the concept of recreational use of drugs at an early age. Look-alikes also divert the efforts of law enforcement officials whose time is better spent on efforts to control illegal distribution of controlled substances. However, look-alikes do produce severe to life-threatening effects including seizures, hypertensive crises, and psychoses. Unfortunately, there are no fast and easy solutions to the stimulant drug abuse problem. Abuse of CNS stimulants has a long history. Effective approaches must involve greater education about the dangers of these drugs and improved recognition among medical professionals of trends in CNS stimulant abuse in order to better diagnose and treat resulting problems. It is unlikely that federal controls on amphetamine production can be increased. The OTC drugs, such as PPA, caffeine, and ephedrine could be moved to prescription-only status to emphasize their potential for abuse and for producing adverse reactions, but this approach is counter to society's current trend toward self-medication.
Similar articles
-
[Current data on methamphetamine].Rev Prat. 2012 May;62(5):679-81. Rev Prat. 2012. PMID: 22730802 Review. French.
-
Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25.Addict Behav. 2007 May;32(5):1003-15. doi: 10.1016/j.addbeh.2006.07.010. Epub 2006 Aug 22. Addict Behav. 2007. PMID: 16920275
-
"Pharming": the abuse of prescription and over-the-counter drugs in teens.Curr Opin Pediatr. 2007 Jun;19(3):270-4. doi: 10.1097/MOP.0b013e32814b09cf. Curr Opin Pediatr. 2007. PMID: 17505185 Review.
-
Psychoactive drug abuse in older adults.Am J Geriatr Pharmacother. 2006 Dec;4(4):380-94. doi: 10.1016/j.amjopharm.2006.10.002. Am J Geriatr Pharmacother. 2006. PMID: 17296542 Review.
-
National drug control policy and prescription drug abuse: facts and fallacies.Pain Physician. 2007 May;10(3):399-424. Pain Physician. 2007. PMID: 17525776 Review.
Cited by
-
Methamphetamine and the expanding complications of amphetamines.West J Med. 1999 Apr;170(4):214-9. West J Med. 1999. PMID: 10344175 Free PMC article. Review.
-
Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.Am J Drug Alcohol Abuse. 2009;35(3):161-77. doi: 10.1080/00952990902825447. Am J Drug Alcohol Abuse. 2009. PMID: 19462300 Free PMC article. Review.
-
Effect of Abstinence on Depression, Anxiety, and Quality of Life in Chronic Methamphetamine Users in a Therapeutic Community.Int J High Risk Behav Addict. 2015 Sep 1;4(3):e23903. doi: 10.5812/ijhrba.23903. eCollection 2015 Sep. Int J High Risk Behav Addict. 2015. PMID: 26495258 Free PMC article.
-
Neurologic manifestations of chronic methamphetamine abuse.Neurol Clin. 2011 Aug;29(3):641-55. doi: 10.1016/j.ncl.2011.05.004. Epub 2011 Jun 24. Neurol Clin. 2011. PMID: 21803215 Free PMC article. Review.
-
Neurologic manifestations of chronic methamphetamine abuse.Psychiatr Clin North Am. 2013 Jun;36(2):261-75. doi: 10.1016/j.psc.2013.02.005. Epub 2013 Apr 11. Psychiatr Clin North Am. 2013. PMID: 23688691 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical